Who Buys Furosemide from India — 778 Importers Behind a $70.5M Market
India's furosemide import market is served by 778 active buyers who collectively imported $70.5M across 4,657 shipments. BAXTER HEALTHCARE CORPORATION (UNITED STATES) leads with a 20.5% market share, followed by RISING PHARMA HOLDINGS, INC. and RISING PHARMA HOLDINGS INC. The top 5 buyers together control 43.2% of total import value, reflecting a moderately competitive buyer landscape.
Top Furosemide Importers — Ranked by Import Value
BAXTER HEALTHCARE CORPORATION (UNITED STATES) is the leading furosemide importer from India, holding a 20.5% share of the $70.5M market across 4,657 shipments from 778 buyers. The top 5 buyers — BAXTER HEALTHCARE CORPORATION (UNITED STATES), RISING PHARMA HOLDINGS, INC. (UNITED STATES), RISING PHARMA HOLDINGS INC (UNITED STATES), RISING PHARMA HOLDINGS INC,., (UNITED STATES), SALUTAS PHARMA GMBH (GERMANY) — collectively control 43.2% of total import value.
Top Furosemide Buyers & Importers
Ranked by import value · 778 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | BAXTER HEALTHCARE CORPORATIONUNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $14.4M | 5 | 20.5% |
| 2 | RISING PHARMA HOLDINGS, INC.UNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $6.3M | 5 | 8.9% |
| 3 | RISING PHARMA HOLDINGS INCUNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $4.2M | 5 | 5.9% |
| 4 | RISING PHARMA HOLDINGS INC,.,UNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $3.6M | 5 | 5.0% |
| 5 | SALUTAS PHARMA GMBHGERMANY FUROSEMIDE TAB 40MG IN91 SH EU 02 MATERIFUROSEMIDE TAB 40MG IN91 SH EU 02 MATERIAL NO - 42024057MATERIAL NO - 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 | $2.1M | 5 | 2.9% |
| 6 | HOSPIRA INCUNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $1.9M | 5 | 2.7% |
| 7 | VIATRIS SANTEFRANCE FUROSEMIDE TABLETS 40MG (FUROSEMIDE ARROFUROSEMIDE TABLETS 40MG(FUROSEMIDE ARROWFUROSEMIDE TABLETS 40 MG | $1.6M | 5 | 2.2% |
| 8 | MARCAN PHARMACEUTICALS INC.,CANADA FUROSEMIDE INJ.40MG/4MLX25 MAR CA SN (NOHARMLESS MEDICINES MINT-FUROSEMIDE (FUFUROSEMIDE INJECTION USP 4 ML | $1.5M | 5 | 2.1% |
| 9 | AVET PHARMACEUTICALS INC.UNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $1.5M | 5 | 2.1% |
| 10 | ATHENEX PHARMACEUTICAL DIVISIONUNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $1.3M | 5 | 1.8% |
| 11 | APL SWIFT SERVICES MALTA LIMITEDMALTA FUROSEMIDE INOVAMEDFUROSEMIDE AUROBINDO 40MG TABLETTENFUROSEMIDE AUROBINDO 40MG TABLETTEN (FUR | $1.3M | 5 | 1.8% |
| 12 | NORTHSTAR DISTRIBUTION CENTERUNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $1.3M | 5 | 1.8% |
| 13 | BAXTER HEALTHCARE CORPORATION.UNITED STATES FUROSEMIDE INJ USP 10MG/ML4MLGV AIN00221FUROSEMIDE INJ USP 10MG/ML2MLGV AIN00218FUROSEMIDE INJECTION USP10MG/ML 10ML GVAIN00214 | $1.3M | 5 | 1.8% |
| 14 | ARROW GENERIQUES,FRANCE FUROSEMIDE TABLETS 40MG (FUROSEMIDE ARROFUROSEMIDE TABLETS 40MG(FUROSEMIDE ARROWFUROSEMIDE TABLETS 40 MG | $1.3M | 5 | 1.8% |
| 15 | STERIMAX INCCANADA FUROSEMIDE INJ.40MG/4MLX25 MAR CA SN (NOHARMLESS MEDICINES MINT-FUROSEMIDE (FUFUROSEMIDE INJECTION USP 4 ML | $1.1M | 5 | 1.6% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Furosemide — and from which countries?
Flow of Furosemide exports from India: each country's share and the named importers behind the numbers
Furosemide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $42.5M through 1,889 shipments. This represents a market share of 60.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• BAXTER HEALTHCARE CORPORATION - $14.4M (34.0% of country's total business)
• RISING PHARMA HOLDINGS, INC. - $6.3M (14.7% of country's total business)
• RISING PHARMA HOLDINGS INC - $4.2M (9.8% of country's total business)
• RISING PHARMA HOLDINGS INC,., - $3.6M (8.4% of country's total business)
• HOSPIRA INC - $1.9M (4.4% of country's total business)
• Rest of United States's importers - $12.2M (28.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $22.5K, indicating premium pricing strategy compared to the market average of $15.1K.
United States is a key market for Furosemide imports, representing 60.2% of total trade value.
2Canada
Canada emerges as the second largest importing country, achieving a total trade value of $5.1M through 53 shipments. This represents a market share of 7.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• MARCAN PHARMACEUTICALS INC., - $1.5M (28.8% of country's total business)
• STERIMAX INC - $1.1M (21.9% of country's total business)
• MINT PHARMACEUTICALS INC - $936.7K (18.3% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $96.8K, indicating premium pricing strategy compared to the market average of $15.1K.
Canada is a key market for Furosemide imports, representing 7.3% of total trade value.
3France
France emerges as the third largest importing country, achieving a total trade value of $4.3M through 89 shipments. This represents a market share of 6.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• VIATRIS SANTE - $1.6M (36.3% of country's total business)
• ARROW GENERIQUES, - $1.3M (28.9% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $48.9K, indicating premium pricing strategy compared to the market average of $15.1K.
France is a key market for Furosemide imports, representing 6.2% of total trade value.
4Germany
Germany emerges as the fourth largest importing country, achieving a total trade value of $2.1M through 64 shipments. This represents a market share of 2.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• SALUTAS PHARMA GMBH - $2.1M (100.0% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $32.2K, indicating premium pricing strategy compared to the market average of $15.1K.
Germany is a key market for Furosemide imports, representing 2.9% of total trade value.
5South Africa
South Africa emerges as the fifth largest importing country, achieving a total trade value of $1.6M through 0 shipments. This represents a market share of 2.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $1.6M, indicating premium pricing strategy compared to the market average of $15.1K.
South Africa is a key market for Furosemide imports, representing 2.2% of total trade value.
Buyer Segment Analysis
TransData Nexus Furosemide buyer market intelligence
1Buyer Segment Analysis
The importers of Furosemide from India can be categorized into several key segments:
1. Distributors: These entities purchase large quantities of Furosemide to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior is characterized by bulk orders and a focus on cost-effectiveness. Notable distributors among the top buyers include:
2. Contract Manufacturers: These companies procure Furosemide as an active pharmaceutical ingredient (API) to produce finished dosage forms for other brands or companies. Their procurement patterns are aligned with production schedules and client demands. Among the top buyers:
Each segment exhibits distinct purchasing behaviors. Distributors often engage in regular, high-volume purchases to maintain a steady supply chain, while contract manufacturers' orders are more variable, depending on production cycles and contractual obligations.
Country-Specific Import Regulations
TransData Nexus Furosemide buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Furosemide in the top importing countries is crucial for market entry and compliance. Below is an overview for each country:
1. United States
2. Canada
3. France
4. Germany
5. South Africa
Demand Drivers & Market Opportunity
TransData Nexus Furosemide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Furosemide in importing countries is driven by several factors:
1. Disease Prevalence: Furosemide is primarily used to treat conditions such as congestive heart failure, liver cirrhosis, and renal impairment. The prevalence of these conditions, particularly in aging populations, contributes to sustained demand.
2. Government Healthcare Programs: Many countries have national health programs that subsidize essential medications, including Furosemide, ensuring widespread accessibility.
3. Universal Health Coverage Expansion: Efforts to expand health coverage increase the patient base eligible for treatment with Furosemide, thereby boosting demand.
4. WHO Essential Medicines List Procurement: Furosemide's inclusion in the World Health Organization's Essential Medicines List encourages its procurement by various health organizations and governments.
5. Tender-Based Purchasing: Many countries procure pharmaceuticals through tender systems, leading to bulk purchases of Furosemide to meet public health needs.
With 778 buyers across 150 countries, the global reach and consistent demand for Furosemide underscore its critical role in managing cardiovascular and renal conditions worldwide.
Common Questions — Furosemide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest furosemide buyer importing from India?
Based on import volume and value, BAXTER HEALTHCARE CORPORATION (UNITED STATES) leads with $14.4M in imports and a 20.5% market share — the highest of any single furosemide importer. RISING PHARMA HOLDINGS, INC. (UNITED STATES) and RISING PHARMA HOLDINGS INC (UNITED STATES) are the next largest buyers.
QHow many companies buy furosemide from India?
There are 778 active furosemide buyers importing from India, with a combined market of $70.5M across 4,657 shipments to 150 countries. The top 5 buyers hold 43.2% of total import value, while the remaining 773 buyers handle the other 56.8%.
QWhich countries import the most furosemide from India?
The top importing countries for furosemide from India are United States (60.2%), Canada (7.3%), France (6.2%), Germany (2.9%), South Africa (2.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of furosemide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for furosemide from India?
The average import transaction value for furosemide from India is $15.1K, with an average unit price of $1.74 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Furosemide buyer market intelligence
1Buyer Segment Analysis
The importers of Furosemide from India can be categorized into several key segments:
1. Distributors: These entities purchase large quantities of Furosemide to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior is characterized by bulk orders and a focus on cost-effectiveness. Notable distributors among the top buyers include:
2. Contract Manufacturers: These companies procure Furosemide as an active pharmaceutical ingredient (API) to produce finished dosage forms for other brands or companies. Their procurement patterns are aligned with production schedules and client demands. Among the top buyers:
Each segment exhibits distinct purchasing behaviors. Distributors often engage in regular, high-volume purchases to maintain a steady supply chain, while contract manufacturers' orders are more variable, depending on production cycles and contractual obligations.
Country-Specific Import Regulations
TransData Nexus Furosemide buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Furosemide in the top importing countries is crucial for market entry and compliance. Below is an overview for each country:
1. United States
2. Canada
3. France
4. Germany
5. South Africa
Demand Drivers & Market Opportunity
TransData Nexus Furosemide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Furosemide in importing countries is driven by several factors:
1. Disease Prevalence: Furosemide is primarily used to treat conditions such as congestive heart failure, liver cirrhosis, and renal impairment. The prevalence of these conditions, particularly in aging populations, contributes to sustained demand.
2. Government Healthcare Programs: Many countries have national health programs that subsidize essential medications, including Furosemide, ensuring widespread accessibility.
3. Universal Health Coverage Expansion: Efforts to expand health coverage increase the patient base eligible for treatment with Furosemide, thereby boosting demand.
4. WHO Essential Medicines List Procurement: Furosemide's inclusion in the World Health Organization's Essential Medicines List encourages its procurement by various health organizations and governments.
5. Tender-Based Purchasing: Many countries procure pharmaceuticals through tender systems, leading to bulk purchases of Furosemide to meet public health needs.
With 778 buyers across 150 countries, the global reach and consistent demand for Furosemide underscore its critical role in managing cardiovascular and renal conditions worldwide.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 778 global importers of Furosemide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 4,657 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 150 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,657 Verified Shipments
778 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists